OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Chair exercised or converted 1 VRTX derivative securities | OQRO

Home
Insider trades
Vertex Pharmaceuticals
Chair exercised or converted 1 VRTX derivative securities

Insider trades

Insider trade

Chair exercised or converted 1 VRTX derivative securities

Traded Dec 4, 2025 · Filed Dec 5, 2025

VRTVertex PharmaceuticalsVRTX

1
Shares · @ $91.05

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 4, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 5, 2025

ChairOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000875320-25-000242

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Dec 5, 2025, 9:10 PM UTC

Added to OQRO

Oct 2, 2026, 12:29 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

VERTEX PHARMACEUTICALS INC / MA

Issuer CIK

875320

Ticker

VRTX

Reporting person

Jeffrey M Leiden

Relationship

Director, Officer

Officer title

Executive Chairman

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Dec 4, 2025

Transaction code

Shares / units

Price per share

$91.05

Acquired / disposed

Acquired (A)

Shares owned after

24,027

Ownership form

Direct

Amendment

Around the same time

Charles F Jr Wagner (EVP, CO & FO) sold ~$3.16M of Vertex Pharmaceuticals

Scheduled in advanceFiled 10mo ago

Charles F Jr Wagner (EVP, CO & FO) sold ~$3.23M of Vertex Pharmaceuticals

Scheduled in advanceFiled 10mo ago

Ourania Tatsis (EVP, Chief Reg. & Quality Off.) sold ~$2.02M of Vertex Pharmaceuticals

Scheduled in advanceFiled 10mo ago